Veterinary Research (Jan 2019)

Effect of anacardic acid against echinococcosis through inhibition of VEGF-induced angiogenesis

  • Miaomiao Yuan,
  • Xiaoxia Song,
  • Wei Lv,
  • Qi Xin,
  • Li Wang,
  • Qi Gao,
  • Guochao Zhang,
  • Wenzhen Liao,
  • Sen Lian,
  • Tao Jing

DOI
https://doi.org/10.1186/s13567-019-0621-7
Journal volume & issue
Vol. 50, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Echinococcosis is a zoonotic infection caused by cestode species of the genus Echinococcus, with limited treatment options. It is urgent to develop new anti-hydatid agent. In this paper, we reported anacardic acid (AA), a natural product isolated from the Brazilian cashew-nut shell liquid, which presented a high activity against metacestodes of Echinococcus multilocularis (E. multilocularis) and Echinococcus granulosus sensu stricto (E. granulosus s.s.) in vitro and in vivo. AA exerted a better efficacy on E. granulosus s.s. protoscoleces and E. multilocularis metacestodes than that of albendazole (ABZ) and dihydroartemisinin (DHA) in vitro, and an inhibition on the growth of Echinococcus metacestode as effective as ABZ in vivo. Moreover, we also found that one of the mechanisms of AA against Echinococcus could be the suppression of angiogenesis on/in the metacestode mass through inhibiting vascular endothelial growth factor (VEGF)—induced signalling pathways. This work finds that AA is a new promising potential candidate drug for echinococcosis treatment.